{"doi":"10.32074/1591-951x-791","title":"In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay","abstract":null,"journal":"Pathologica","year":2022,"id":609327,"datarank":0.5837730447165941,"base_score":3.8918202981106265,"endowment":3.8918202981106265,"self_citation_contribution":0.5837730447165941,"citation_network_contribution":0.0,"self_endowment_contribution":0.5837730447165941,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":48,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":353016,"name":"Ilaria Betella","orcid":"0000-0001-9191-8228","position":1,"is_corresponding":false},{"id":1566080,"name":"Alberto Ranghiero","orcid":null,"position":2,"is_corresponding":false},{"id":88314,"name":"Elena Guerini-Rocco","orcid":null,"position":3,"is_corresponding":false},{"id":1566081,"name":"Giulio Bonaldo","orcid":null,"position":4,"is_corresponding":false},{"id":1566082,"name":"Alessandra Rappa","orcid":null,"position":5,"is_corresponding":false},{"id":1566083,"name":"Davide Vacirca","orcid":null,"position":6,"is_corresponding":false},{"id":50716,"name":"Nicoletta Colombo","orcid":"0000-0003-2225-715X","position":7,"is_corresponding":false},{"id":1213760,"name":"Massimo Barberis","orcid":"0000-0002-0943-4804","position":8,"is_corresponding":false},{"id":852480,"name":"Caterina Fumagalli","orcid":"0000-0001-5417-7985","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay","abstract":null,"is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":null,"authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"gold","license":"cc-by-nc-nd","oa_locations":[{"url":"https://www.pathologica.it/article/download/791/527","host_type":"publisher"},{"url":"https://www.pathologica.it/article/view/791","host_type":"publisher"},{"url":"https://hdl.handle.net/10281/403111","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9624133","host_type":"repository"}],"fields_of_study":[],"mesh_terms":[],"keywords":[],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-31T06:08:15.872175Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}